Meet our advisory board

Pam Garside

Management Consultant


Pam Garside is a management consultant working in health care systems and digital health
in the UK and internationally and an angel investor in early-stage health tech companies. Pam is a Fellow of the Judge Business School of the University of Cambridge and a member of the Investment Committee of Cambridge Enterprise, the technology transfer company
of the University.


Pam founded and co-chairs The Cambridge Health Network (a membership group of senior players in UK health, both private and public sector), is Chairman of Cambridge Angels and sits on the board of Crown Place Venture Capital Trust. Pam is also a board member of several start-ups and she advises a number of life science companies, health technology accelerators and start-ups in the UK and Europe.


Pam began her professional life in management in the NHS and subsequently spent many years studying and working internationally based in the USA. She holds a BSc from the University of Durham and a Masters Degree in Hospital and Health Care Administration from the University of Minnesota. She is an Adjunct Professor at Imperial College Business

James O'Shaughnessy

Senior Partner, Newmarket Strategy


James is one of the UK's leading policy advisors. He has operated at the highest levels of government, including as a Minister at the Department for Health & Social Care, as Director of the No.10 Policy Unit, and as an advisor to DHSC Ministers during the COVID-19 crisis.

James is driven by the twin goals of bringing life-changing health innovations to patients and growing the UK’s life science & health tech


As Minister his responsibilities included implementing the Life Science Industrial Strategy, delivering a new pricing scheme with the pharmaceutical industry, chairing the National Genomics Board, and driving the digital transformation of the NHS. He was also responsible for preparing the health and social care sectors for Brexit and helping to design the post-Brexit regulatory regime.


In 2021 James became co-founder and Senior Partner of Newmarket Strategy, a consultancy dedicated to improving access to health innovation by providing strategic advice and technical support to the healthcare, life sciences and health tech sectors.


At Newmarket, James provides senior counsel to multinationals, SMEs, investors, universities, hospitals and charities, with a particular focus on technology, digital and data. He is a Visiting Professor at the Institute of Global Health Innovation at Imperial College, where he chairs the Data, Health & Wealth programme, and a non-executive director of both Health Data Research UK and the Albion Development VCT plc.


Outside of health, James chairs
the Repairing our Social Fabric programme at the think tank Onward and has a keen interest in
education reform.